New cancer pill shows promise in early trial
Disease control
Recruiting now
This study tests an experimental drug called CP-383 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if CP-383 can slow or stop cancer growth and to find the safest and most effective dose. About 150 participants will take th…
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC